author-photo

Isabelle Monnet

Paris 12 Val de Marne University

258

Papers

5210

Citations

Citation Trend

Filter By

Papers (258) Sort By

JournalConferenceOthers

Nivolumab dans le mésothéliome pleural malin : une étude française rétrospective en vraie vie

2021 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
FP13.01 5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1–Positive Advanced NSCLC

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Platine pemetrexed avec ou sans bevacizumab avec radiothérapie cérébrale initiale versus “à progression” chez des patients ayant un carcinome bronchique non à petites cellules non épidermoïde avec métastases cérébrales asymptomatiques: un essai de phase 3 randomisé (Metal2)

2021 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study.

2021 Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (2)
Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)

2021 Current Oncology
Show All
- Source
- Cite
- Save
Citations (0)
FP09.05 Driver Oncogenic Alterations and Indoor Radon in NSCLC Patients From the IFCT Biomarker Cohort: Bioradon France Study

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus “at progression” cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis:

2021 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
LBA42 COAST: An open-label, randomised, phase II platform study of durvalumab alone or in combination with novel agents in patients with locally advanced, unresectable, stage III NSCLC

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号